More on CRBP
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $8.24 |
|
|||
| Open | $8.24 | ||||
| 52 Wk High | $10.78 | ||||
| 52 Wk Low | $1.01 | ||||
| Day High | $8.24 | ||||
| Day Low | $8.24 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 120 | ||||
- H.C. Wainwright Reiterates Buy Rating on Corbus Pharmaceuticals (CRBP)
- Form 4 Corbus Pharmaceuticals For: Aug 16 Filed by: Nicacio Leonardo Viana
- Corbus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Form SCHEDULE 13G/A Corbus Pharmaceuticals Filed by: CITADEL ADVISORS LLC
- Corbus Pharmaceuticals (CRBP) PT Lowered to $33 at Mizuho
- Form 4 Corbus Pharmaceuticals For: Aug 11 Filed by: Saxena Nishant C
- Form 4 Corbus Pharmaceuticals For: Aug 07 Filed by: Cohen Yuval
- Form 4 Corbus Pharmaceuticals For: Aug 07 Filed by: Moran Sean F.
- Form 424B5 Corbus Pharmaceuticals
- Form 144 Corbus Pharmaceuticals Filed by: Stifel, Nicolaus & Company, Inc CIAS /FA
Entities mentioned with CRBP
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- Jefferies & Co | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Show More...
